SELECT COUNTRY

VIEW ALL
AFRICA
AMERICAS
ASIA
EUROPE
OCEANIA

UNITED STATES: LATEST INTERVIEWS MORE INTERVIEWS

Eddie Pauline
PRESIDENT AND CEO, OHIO LIFE SCIENCES
"Ohio is increasingly competitive in attracting larger, well-known life science brands, plus our institutions continue to spin out new biotech companies; people across the country are starting to notice."
United States
Pharma & Life Sciences
Takahiro Ueda
CEO, CMIC CMO USA
"Continuous manufacturing is key to our US strategy, differentiating us in the market."
United States
Pharma & Life Sciences
Louis P. Kassa III
CEO, PENNSYLVANIA BIOTECHNOLOGY CENTER (PABC)
"Better alignment between institutions and industry can drive innovation, scientific progress, and economic growth in the coming years."
United States
Pharma & Life Sciences
Steve Favaloro
CHAIRMAN AND CEO, GENEZEN
"Investors are finding it difficult to balance early-phase success with the commercialization hurdles ahead."
United States
Pharma & Life Sciences

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL